xenoport inc (XNPT:NASDAQ GS)
Paul L. Berns
Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee, Jazz Pharmaceuticals Public Limited Company
|Age||Total Calculated Compensation||This person is connected to 47 board members in 7 different organizations across 9 different industries.|
See Board Relationships
Mr. Paul L. Berns served as Chief Executive Officer and President of Allos Therapeutics Inc. since March 9, 2006. Mr. Berns was a self-employed consultant to the pharmaceutical industry from July 2005 to March 2006. Mr. Berns served as the President and Chief Executive Officer at Bone Care International Inc. from June 2002 to July 2005. Mr. Berns served as a Vice President and General Manager, Abbott Labs Immunology, Oncology and Pain Therapeutics business unit of Abbott ...
3410 Central ExpresswayPhone: 408-616-7200
Santa Clara, California 95051
Board Members Memberships*
Vice President of Marketing
Former Chief Executive Officer, President and Director
Independent Director and Chairman of Compensation Committee
Chief Executive Officer, President and Executive Director
Director and Member of Audit Committee
Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
University of Wisconsin - Madison
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Richard F. Pops||Chairman of the Board and Chief Executive Officer|
|Jean-Jacques Bienaimé||Chief Executive Officer and Director|
BioMarin Pharmaceutical Inc.
|Vincent J. Milano||Chairman, Chief Executive Officer and President|
|Rajat Rai||Chief Executive Officer|
|Carolyn J. Logan||Chief Executive Officer, President and Director|
Salix Pharmaceuticals Ltd.
|$834.1K||Compensation as of Fiscal Year 2013.|